| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/07/2013 | CN102171205B Pyrazinone modulator of corticotropin-releasing factor receptor activity |
| 08/07/2013 | CN102036988B Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof |
| 08/07/2013 | CN101744906B Applications of Chinese medicinal composition in preparation of medicament for treating facial paralysis |
| 08/07/2013 | CN101679366B Pyridyl piperidine orexin receptor antagonists |
| 08/07/2013 | CN101212969B Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 08/06/2013 | US8502014 Method for the production of a single heavy chain antibody |
| 08/06/2013 | US8501791 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | US8501729 5-HT3 receptor modulators, methods of making, and use thereof |
| 08/06/2013 | US8501728 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 08/06/2013 | US8501423 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 08/06/2013 | US8501244 Chlorite formulations and methods of preparation and use thereof |
| 08/06/2013 | US8501240 Compositions comprising an active agent |
| 08/06/2013 | US8501195 Injection paradigm for administration of botulinum toxins |
| 08/06/2013 | US8501164 Nicotine lozenge compositions |
| 08/06/2013 | CA2771928C Oxazine derivatives and their use in the treatment of neurological disorders |
| 08/06/2013 | CA2758251C Serotonin and norepinephrine reuptake inhibitor |
| 08/06/2013 | CA2652074C Substituted carboxamides as group 1 metabotropic receptor antagonists |
| 08/06/2013 | CA2629065C 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 08/06/2013 | CA2609388C Novel piperidine derivative |
| 08/06/2013 | CA2567513C Histamine h3 receptor agents, preparation and therapeutic uses |
| 08/06/2013 | CA2560741C Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| 08/06/2013 | CA2556450C Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
| 08/06/2013 | CA2521421C C-mycer.tam. induced human neural stem cell lines |
| 08/06/2013 | CA2451839C Pharmaceutical compositions comprising peptides and permeation enhancers |
| 08/06/2013 | CA2368213C Specifically targeted catalytic antagonists and uses thereof |
| 08/01/2013 | WO2013112859A1 Method for enhancing remyelination using gli1 inhibitors |
| 08/01/2013 | WO2013112673A1 Synthetic voacangine |
| 08/01/2013 | WO2013111799A1 Brain function improver |
| 08/01/2013 | WO2013111798A1 Serine racemase inhibitor |
| 08/01/2013 | WO2013111796A1 N-substituted pyrazole derivative |
| 08/01/2013 | WO2013110768A1 Pde9 inhibitors with imidazo triazinone backbone |
| 08/01/2013 | WO2013110698A1 Substituted pyrano and furanoquinolines, their preparation and use as medicaments |
| 08/01/2013 | WO2013110313A1 Selective allosteric modulators of the serotonin transporter |
| 08/01/2013 | WO2013110309A1 Triazolo[4,5-d]pyrimidine derivatives |
| 08/01/2013 | WO2013110135A1 Heterocyclic compounds and methods for their use |
| 08/01/2013 | WO2013110134A1 Heterocyclic compounds and methods for their use |
| 08/01/2013 | WO2013085431A3 Medical food for the dietary management of depression and anxiety and methods thereof |
| 08/01/2013 | WO2013054866A8 Agent for preventing or treating htlv-i associated myelopathy |
| 08/01/2013 | US20130197094 Trpv1 compounds in a biodegradable polymer carrier |
| 08/01/2013 | US20130197020 Method of Providing Sustained Analgesia With Buprenorphine |
| 08/01/2013 | US20130196987 Macrocyclic compounds useful as pharmaceuticals |
| 08/01/2013 | US20130196849 Substituted Cellulose Acetates and Uses Thereof |
| 08/01/2013 | US20130195890 Treatment of ms with goat serum |
| 08/01/2013 | US20130195808 Mesenchymal stem cell and a method of use thereof |
| 08/01/2013 | CA2862535A1 Substituted pyrano and furanoquinolines, their preparation and use as medicaments |
| 08/01/2013 | CA2862532A1 New pharmaceutical compositions containing phosphatidylserine and curcumin |
| 07/31/2013 | EP2620493A1 Mesenchymal stem cells for the treatment of CNS diseases |
| 07/31/2013 | EP2620438A1 Substituted pyrano and furanoquinolines, their preparation and use as medicaments |
| 07/31/2013 | EP2620433A1 Substituted amide compound |
| 07/31/2013 | EP2620431A1 Novel crystals of substituted phenylalkanoic acid and production process |
| 07/31/2013 | EP2620154A1 Drug against central nervous system inflammation |
| 07/31/2013 | EP2620153A1 5 alpha-androstane (alkyl)-3 beta,5,6 beta-triol injection and preparation method therefor |
| 07/31/2013 | EP2619212A1 Buprenorphine analogs |
| 07/31/2013 | EP2619208A1 Imidazotriazinone compounds |
| 07/31/2013 | EP2619207A1 4,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-6-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) |
| 07/31/2013 | EP2619205A1 Monohydrate of an azaadamantane derivative |
| 07/31/2013 | EP2619203A1 Tricyclic compounds, preparation methods, and their uses |
| 07/31/2013 | EP2619202A1 Pyridmidones for treatment of potassium channel related diseases |
| 07/31/2013 | EP2619201A1 Pyrazolopyridines as inhibitors of the kinase lrrk2 |
| 07/31/2013 | EP2619187A1 Compounds and pharmaceutical compositions for treating disorders associated with the 5-ht1a and 5-ht2a receptors |
| 07/31/2013 | EP2618826A1 Phenylpiperidine compounds for the treatment of neurological and psychiatric disorders |
| 07/31/2013 | EP2618820A2 Controlled release formulations of opioids |
| 07/31/2013 | EP2618666A1 Novel dihydropyrimidin-2(1h)-one compounds as neurokinin-3 receptor antagonists |
| 07/31/2013 | CN103228674A Methods and compositions for neural disease immunotherapy |
| 07/31/2013 | CN103228660A Kat II inhibitors |
| 07/31/2013 | CN103228657A 3-hetaryl-substituted pyrrole[2,3-b]pyridine derivatives as pdk1 inhibitors |
| 07/31/2013 | CN103228656A 3-substituted-6-(pyridinylmethoxy)- pyrrolopyridine compounds |
| 07/31/2013 | CN103228631A Kat II inhibitors |
| 07/31/2013 | CN103228618A Novel compound and medical use thereof |
| 07/31/2013 | CN103228284A Methods and compositions for preventing a condition |
| 07/31/2013 | CN103224956A Type-II adeno-associated virus carrying neuritin genes and application thereof in restoring optic nerve injuries |
| 07/31/2013 | CN103224934A Short interfering ribonucleic acid (siRNA) for oral administration |
| 07/31/2013 | CN103224556A Huntingdon disease (HD)-targeted proteins and their coding genes and use |
| 07/31/2013 | CN103224545A Sulfur-containing compound with nerve protection effect and application thereof |
| 07/31/2013 | CN103224539A Gastrodine compound and pharmaceutical composition thereof |
| 07/31/2013 | CN103224497A Inhibitors of protein kinases |
| 07/31/2013 | CN103224492A 14-aryl-ether andrographolide derivative and preparation method and application thereof |
| 07/31/2013 | CN103224487A Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 07/31/2013 | CN103224467A Preparation method of (-)-huperzine A |
| 07/31/2013 | CN103224466A Compound with beta-secretase inhibition function, its preparation method and application |
| 07/31/2013 | CN103223177A Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
| 07/31/2013 | CN103223138A Traditional Chinese medicine abstinent medicine |
| 07/31/2013 | CN103223123A Perimenopausal syndrome treatment drug composition, preparation method and uses thereof |
| 07/31/2013 | CN103223122A Traditional Chinese medicine for treating stubborn headache |
| 07/31/2013 | CN103223121A Pill for treating hemiplegia |
| 07/31/2013 | CN103223120A Traditional Chinese medicine preparation for treating nerve headache |
| 07/31/2013 | CN103223118A Traditional Chinese medicine composition for treating facial paralysis |
| 07/31/2013 | CN103223088A Traditional Chinese medicine for treating yin deficiency and blood stasis syndrome of Parkinson's disease |
| 07/31/2013 | CN103223080A Traditional Chinese medicinal composition for tranquilizing mind by nourishing the heart and preparation method thereof |
| 07/31/2013 | CN103223074A Wound treating capsule and preparation method |
| 07/31/2013 | CN103223038A Traditional Chinese medicine composition for warming kidney and invigorating spleen and preparation method thereof |
| 07/31/2013 | CN103223027A Medicinal preparation for treating and preventing vegetative nerve functional disturbance diseases |
| 07/31/2013 | CN103223006A Traditional Chinese medical composition for treating facial paralysis |
| 07/31/2013 | CN103222983A Use of peracetylated chitooligosaccharide in preparing drug for treating neurodegenerative disease |
| 07/31/2013 | CN103222966A Solid pharmaceutical composition containing Fingolimod hydrochloride and preparation method thereof |
| 07/31/2013 | CN103222597A Applications of instant asparagus powder in food, drugs and health food |
| 07/31/2013 | CN102861147B Traditional Chinese medicine composition for treating carbon monoxide delayed encephalopathy |
| 07/31/2013 | CN102614399B Medicine composition for treating headache after craniocerebral operations |
| 07/31/2013 | CN102406780B Traditional Chinese medicine composition used for drug abstinence |